Pharmaceutical industry news

£162 million boost for vital UK life sciences and materials research

Scholar Rock’s muscle-targeting SMA therapy Isemblyd lands FDA approval

BD Advances Intelligent Robotics to Transform the Future of Pharmacy Care at Fairview

Best Income Stocks to Buy for September 14th

Stifel cuts Olema Pharmaceuticals price target on trial concerns

Lonza deepens US bet with commercial plant in Oregon

FDA Approves Telix’s Brain Cancer Imaging Drug Pixclara

U.S. FDA Accepts New Drug Application Under Priority Review for Takeda’s Zasocitinib in Moderate-to-Severe Plaque Psoriasis, with Potential to Redefine Oral Treatment Expectations

Alcon warns that US proposal could cause companies to abandon Europe

The FDA’s Proposed Drug Ad Rule Is a Blueprint for Violating the First Amendment

First-in-Human Clinical Trial Attacks Pancreatic Cancer With Laser Light

FDA grants priority review to Takeda (NYSE: TAK) pill for severe psoriasis

New rehabilitation gym on hospital ward to help speed up recovery

Merck provides Keytruda at no cost for a cancer trial

Circulating tumor DNA-guided de-escalation or escalation of adjuvant therapy in high-risk stage II and stage III colon cancer: the phase 2 PEGASUS trial

Morocco’s Pharmaceutical Trade Deficit to Reach $1.4 Billion by 2030

Speaker Fees and Buy-and-Bill Keep Doctors Loyal to Pharma

Why Fragmented Contract Processes Are Slowing Pharmaceutical Operations

Could Western Mass be to food’s future what Boston is to biotech? UMass is betting on it with $120 million.

Pharmaceutical Industry Corruption Is Structural, Systemic, and Profitable, New Review Finds

RTW Biotech makes 16.5% half-year return as surge in listed drug developers outweighs write-down of Ensoma

Roche notches ph. 3 lung cancer win but trails GSK on survival

A fourth Ukrainian pharmaceutical warehouse has burned in a Russian strike since the start of the month

What supplement formulators can borrow from pharmaceutical delivery science

PM stresses strengthening Egypt’s pharmaceutical industry, regulatory system

RTW Biotech Opportunities Ltd 2026 Q2 - Results - Earnings Call Presentation (OTCMKTS:RTWFF) 2026-09-14

GLP-1 at Scale: How the Boom in Semaglutide Is Reshaping Cold Chain Packaging

Gotistobart nearly doubles survival in pretreated squamous lung cancer

Trump's Drug Policy May Raise South Korea Prices

Ganpati prasad under FDA watch: Maharashtra societies told to follow new food safety rules

Scholar Rock wins FDA approval for Isembyld

Designing The Exit: IP Strategy For Venture-Backed Biotech - Patent - United Kingdom

School Food Standards: updating the legislative framework

Seeking views on updating the School Food Standards, so that every school is supported with the late...

Act, align, accelerate: Europe’s Biotech turning point

Confirmatory Evidence for All? FDA’s Approval of Lytenava for Wet AMD Shows How Non-Rare Diseases Can Use Confirmatory Evidence and That “Failed” Studies Can Provide Confirmatory Evidence

Septembre, mois de sensibilisation aux cancers du sang : un don de soi au bénéfice des malades pour les agents des HUS

Spain Pushes EU-Wide Market Access Toolbox for Innovative Biotech Medicines

China has a chokehold on your medicine cabinet. It’s a national security threat

Veranex and MDIC Launch EFS Explorer to Streamline Early Feasibility Study Site Selection

Aortic structure may affect midlife rise in pulse pressure, aortic stiffness in women

Endométriose : les HUS font évoluer la prise en charge des patientes

België blijft bij Europese top in life sciences, maar Europa verliest de innovatierace

Hong Kong Stocks Rise on Monday on Tech, Biotech Gains; Trigiant Jumps 47%

BioNTech says lung cancer drug candidate prolonged lives in trial

A Prefix Is No Shield Against Confusion: Delhi High Court Protects BIOCHEM

BioNTech says lung cancer drug candidate prolonged lives in trial

Why is our tax system so complicated?

UK Clinical Research Delivery key performance indicators: data to September 2026

Report bringing together data on the delivery of globally competitive clinical research through the...

Novo will adapt to the changing healthcare market with a new visual identity

Présentation du futur chantier des façades Garonne de La Grave à la Fondation du Patrimoine

How Trump’s pharmaceutical plan threatens Europe: Higher drug prices and delays in new therapies

Russia strikes fourth Ukrainian pharmaceutical warehouse in September - VIDEO

Prestigious fellowship to uncover how our gut microbiome tackles dietary xenobiotics

BioNTech and OncoC4 Report Updated Phase 3 Data Showing Gotistobart Nearly Doubles Overall Survival in Squamous NSCLC

Taiho Pharmaceutical Co., Ltd., Taiho Oncology, Inc., and Cullinan Therapeutics, Inc. Reports Results From Phase 3 REZILIENT3 Trial Evaluating Zipalertinib Plus Chemotherapy In First-Line EGFR Exon 20 Insertion Mutation Non-Small Cell Lung Cancer

Quarterly Epidemiological Commentary: mandatory MRSA, MSSA and Gram-negative bacteraemia and Clostridioides difficile infection, data up to April to June 2026

Epidemiological analyses of mandatory surveillance data on healthcare associated infections (HCAI);...

BioNTech's Gotistobart: A Breakthrough in Lung Cancer Treatment

GSK presents positive registrational data to potentially expand Jideytro (zidesamtinib) to first-line ROS1-positive non-small cell lung cancer

BioNTech’s experimental treatment extended survival to 18.5 months, versus 10

Vivian L. Borrero, RAC, Achieves Recognition for 40 Years of Leadership and Contributions to Pharmaceutical and Medical Technology